The prodrug APR-246 is converted to the Michael acceptor MQ that reactivates mutant p53 and also induces oxidative stress by targeting redox regulators such as TrxR1, thioredoxin, and glutathione, leading to tumor cell death by apoptosis [45]. Here, TXN is linked to neoplasm.